Free Trial

Neurocrine Biosciences (NBIX) SEC Filings & 10K Form

Neurocrine Biosciences logo
$120.69 +4.58 (+3.94%)
Closing price 04:00 PM Eastern
Extended Trading
$120.78 +0.09 (+0.08%)
As of 05:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Neurocrine Biosciences SEC Filings

DateFilerForm TypeView
02/14/2025
6:13 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:49 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:57 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:35 PM
Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:42 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:13 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:20 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:26 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:00 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:03 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:08 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:33 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:33 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:33 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM
Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM
Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM
Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM
Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:38 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:38 PM
Neurocrine Biosciences (Subject)
SHERWIN STEPHEN A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
5:41 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:44 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:46 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:48 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:49 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:52 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:56 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
6:00 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
3:51 PM
Neurocrine Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2025
3:04 PM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
5:50 AM
Neurocrine Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad)

If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.

02/04/2025
5:05 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:42 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:45 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:47 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:49 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:51 PM
Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:54 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:58 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:31 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:35 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:19 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:32 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:32 PM
Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:33 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:34 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:29 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:27 PM
Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:29 PM
BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
6:03 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:27 PM
GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:19 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
3:17 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
7:06 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
3:37 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:47 PM
Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:29 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
5:52 PM
Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
12:41 PM
Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
6:42 PM
Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
6:52 PM
Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
7:31 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:02 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:04 AM
Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2024
8:54 AM
Neurocrine Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
09/17/2024
3:21 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:23 PM
Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
6:00 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:00 PM
Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:06 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:12 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:21 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
4:16 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:18 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:40 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
9:51 AM
Neurocrine Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
6:03 AM
Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:04 AM
Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
The FED is losing the war on inflation (Ad)

It's no longer just a “guesstimate” – Inflation is indeed getting worse. And although we want to believe the Fed has a good grip on it, they don't. Right now, the suits over there are caught between a rock and a hard place. Either they watch as inflation grows, or they tear it down and send us into a full-blown recession. The kicker here is that neither of these are good for you. Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower. The only real way out for the regular person is to increase your earning power. By increasing your income to match prices as they flare up… You’ll stay ahead of the impending doom we're running face-first into. And if you're looking for a strategy to help increase your income in 2025… I've got just the thing for you! You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts But I changed my trading rules and more than doubled my results on those 100 published trades. I'm now calling them Warped Options…

You can go here to give yourself a head start.
07/18/2024
3:54 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:00 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:12 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:45 PM
ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:41 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:28 PM
Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:29 PM
Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:29 PM
LYONS GARY A (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:30 PM
Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NBIX) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners